Skip to main content
Premium Trial:

Request an Annual Quote

GenomeWebinars

Tue
Feb
11
10:00 AM
US Eastern

Sponsored by Qiagen

Genomics for Health Webinar Series: Mapping the Human Body One Cell at a Time

This webinar is the first of a series on Genomics for Health.

 

The 37 trillion cells of the human body have a remarkable array of specialized functions and must cooperate in time and space to construct a functioning human.

 

In this webinar, Sarah Teichmann, professor of stem cell medicine at the University of Cambridge and co-founder and co-leader of the International Human Cell Atlas Consortium, will discuss how her lab harnesses cutting-edge single-cell and spatial genomics to better understand this cellular diversity — specifically how distinct microenvironments regulate cell identity. The lab’s spatial atlas of the adult human heart includes the first comprehensive map of the conduction system, and it harnessed the unique molecular signature of the very rare pacemaker cells to make predictions about potential drug activities. Moving from the single organ to the systems level, Teichmann’s team revealed the context-specific and context-agnostic features of the vasculature across the body. Finally, the team has taken cell atlases into 3D and 4D with its thymus atlases. Studying thymus development uncovered the rules of T-cell identity, which Teichmann’s team then harnessed in the dish to engineer T cells from thymic organoids. The lab also used advanced spatial and computational methods to map T-cell development to a continuous tissue axis, identifying the key spatial and temporal features of this crucial developmental trajectory.

 

ABOUT THE SERIES

 

 

Genomics for Health Webinar Series: Exploring the Transformative Power of Genomics in the Prediction, Prevention, Diagnosis, and Treatment of Diseases

 

The “Genomics for Health” webinar series is a unique forum for academic researchers, industry professionals, and healthcare practitioners to come together and explore how genomics is reshaping the future of healthcare. From prediction and prevention to diagnosis and treatment — including drug development — this series highlights genomics’ transformative role in empowering patient-centered care.

 

Led by Vijay Tiwari, professor and head of research at the Institute of Molecular Medicine at the University of Southern Denmark, and Marc Sultan, principal leader of genetics and genomics at Roche, the three-part webinar series aims to inspire a global audience to harness the potential of genomics for innovation in healthcare. Together, Tiwari and Sultan will offer unique perspectives on how academia and industry can work together to advance genomics in precision medicine, driving meaningful conversations and actionable insights. Each of the three webinars will feature different speakers, who will discuss their current work, offering real-world case studies and identifying key challenges and opportunities for collaboration in the field of genomics.

Sponsored by

Qiagen
Tue
Feb
18
11:00 AM
US Eastern

Sponsored by Olink

Using NGS-Based Proteomics to Differentiate BTK Inhibitor Response in Leukemia

Treatment of chronic lymphocytic leukemia (CLL) has been revolutionized by targeted therapies, especially BTK inhibitors (BTKi), which block signaling of the B cell receptor, depriving leukemia cells of survival signals. BTKi have significantly improved the survival of CLL patients and are now a preferred standard therapy for CLL.

 

This webinar will highlight a study that set out to compare the effect of three different BTK inhibitors: ibrutinib, acalabrutinib, and zanubrutinib. Patient samples were obtained before and at various timepoints after treatment to identify biomarkers that could be informative of the treatment’s effect and potential side effects.

 

In the study, a new method from Olink, called Olink Reveal, enabled the identification of numerous proteins. The method quantifies more than 1,000 proteins, representing a full range of biological pathways across the proteome, and is enriched with hundreds of proteins involved in inflammation processes. This approach enabled the identification of numerous proteins, including those differing between the studied compounds, and shows promise for other studies seeking to compare the effects of different cancer treatments.

 

This presentation will share the first data to characterize the effects of the different BTKi on plasma biomarker levels and will be followed by an introduction to Olink Reveal.

 

Presenters:

 

C. I. Edvard Smith, Professor, Department of Laboratory Medicine at the Karolinska Institute

Kerhan Woo, Product Manager, Olink Proteomics

Sponsored by

Olink
Mon
Feb
24
1:00 PM
US Eastern

Sponsored by Agena Bioscience

Expert Panel: Guideline-Driven Pharmacogenomic Testing and the Trajectory of Utilization

In this webinar, attendees will hear from a panel of experts in the pharmacogenomics (PGx) space. These thought leaders will discuss consensus recommendations for standardization of alleles for pharmacogenomic genotyping assays. Attendees will gain insights into these evidence-based guidelines and the implementation of standardized PGx testing within the laboratory. This panel discussion will provide insights into the trajectory of PGx utilization, including challenges, future considerations, and the potential benefits to healthcare.

Sponsored by

field_file_image_alt_text_value
Thu
Mar
06
1:00 PM
US Eastern

Sponsored by Illumina

Scaling the Genomics Lab for the Data Deluge: Streamlined and Efficient Data Analysis Workflows as a Strategic Pillar for Growth

The exponential growth of genomic data has created both opportunities and challenges for laboratories striving to scale operations across service lines. To address this data deluge, leveraging bioinformatics as a core strategy has become essential.

 

This webinar will explore how a leading genomics lab, the Advanced Precision Medicine Laboratory (APML) at the Jackson Laboratory, harnesses a streamlined bioinformatics workflow to enhance data integration and support scalability while maintaining accuracy and efficiency. APML has implemented Illumina Connected Software covering all their data needs from LIMS through analysis and variant interpretation. Melissa Kelly, clinical laboratory director of the Advanced Precision Medicine Laboratory, will explore how an integrated data ecosystem from sample management through interpretation helps her team get the result they can trust faster.

 

Kevin Moore, vice president of software product management at Illumina, will wrap up the presentation with a quick overview of the upcoming software advancements and how it will enable seamless end-to-end multiomics workflows.

Attendees will learn to:

  • Build effective lab infrastructure with practical approaches.
  • Align bioinformatics solutions with operational needs.
  • Position labs for sustainable growth in an era of increasing data complexity.
  • Harness the latest advancements in Illumina software that enable seamless integrated multiomics workflows.

Sponsored by

Illumina